Tibet Nafei Pharmaceutical

Tibet Nafei Pharmaceutical is a Chinese pharmaceutical company headquartered in Lhasa, Tibet, operating as a wholly-owned subsidiary of the Haisco Pharmaceutical Group. The company specializes in the manufacturing and commercialization of high-end chemical drugs, with a particular emphasis on anesthesiology, intensive care, and cardiovascular treatments. It serves as a primary production site for Haisco's innovative pipeline, including specialized injectable emulsions and small molecule therapies. Tibet Nafei is responsible for the market supply of key products such as Ciprofol, an innovative anesthetic, and clevidipine butyrate for hypertensive emergencies. The company's strategic location in Tibet allows it to benefit from regional development policies while supporting Haisco's broader clinical and commercial objectives across China.